These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1746595)

  • 21. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII.
    Gharagozlou S; Ghods R; Bahrami ZS; Roohi A; Jeddi-Tehrani M; Conti-Fine BM; Sharifian RA; Rabbani H; Shokri F
    Hum Antibodies; 2003; 12(3):67-76. PubMed ID: 14646035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimer formation in immunoglobulin preparations and speculations on the mechanism of action of intravenous immune globulin in autoimmune diseases.
    Tankersley DL
    Immunol Rev; 1994 Jun; 139():159-72. PubMed ID: 7927410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg).
    Macias A; Arce S; Leon J; Mustelier G; Bombino G; Domarco A; Perez R; Lage A
    Hybridoma; 1999 Jun; 18(3):263-72. PubMed ID: 10475241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping of natural anti-factor VIII antibodies in plasma pools from healthy donors: use of rationally designed synthetic peptides.
    Di Giambattista M; Branckaert T; Laub R
    Biologicals; 2001; 29(3-4):229-32. PubMed ID: 11851320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-idiotypic suppression of autoantibodies with high dose intravenous immunoglobulins.
    Kazatchkine MD
    Prog Clin Biol Res; 1990; 337():411-4. PubMed ID: 2112754
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-idiotypic antibodies: from regulation to therapy of factor VIII inhibitors.
    Saint-Remy JM; Jacquemin MG; Gilles JG
    Vox Sang; 1999; 77 Suppl 1():21-4. PubMed ID: 10529681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg).
    Dietrich G; Algiman M; Sultan Y; Nydegger UE; Kazatchkine MD
    Blood; 1992 Jun; 79(11):2946-51. PubMed ID: 1586740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.
    Gilles JG; Saint-Remy JM
    J Clin Invest; 1994 Oct; 94(4):1496-505. PubMed ID: 7523452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors.
    Sakurai Y; Shima M; Tanaka I; Fukuda K; Yoshida K; Yoshioka A
    Haematologica; 2004 Jun; 89(6):696-703. PubMed ID: 15194537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothesis for the control of clotting factor VIII inhibitory antibodies by decreasing potency of helper T-cell-recognized epitopes in factor VIII.
    Tiarks C; Humphreys RE; Anderson J; Mole J; Pechet L
    Scand J Immunol; 1992 Nov; 36(5):653-60. PubMed ID: 1279780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural antibodies to factor VIII.
    Lacroix-Desmazes S; Moreau A; Pashov A; Sooryanarayana ; Stahl D; Saint-Remy JM; Kaveri SV; Kazatchkine MD
    Semin Thromb Hemost; 2000; 26(2):157-65. PubMed ID: 10919408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
    Hurez V; Kaveri SV; Kazatchkine MD
    J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of anti-idiotypic antibodies in immune tolerance induction.
    Gilles JG
    Haemophilia; 2010 May; 16(102):80-3. PubMed ID: 20536989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.
    Mouthon L; Kaveri S; Kazatchkine M
    Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steroid-responsive type II anti-factor VIII:C autoantibody in a nonhemophiliac child.
    Carter CJ; Devine DV; Rogers PC; Wadsworth LD
    Am J Pediatr Hematol Oncol; 1990; 12(2):205-9. PubMed ID: 2116097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor VIII epitopes recognized with inhibitory monoclonal antibodies.
    Tiarks CY; Humphreys RE; Pechet L
    Acta Haematol; 1990; 83(2):69-75. PubMed ID: 1689530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perspectives on the use of factor IX complex concentrates in the treatment of bleeding in persons with acquired factor VIII inhibition.
    Lusher JM
    Am J Med; 1991 Nov; 91(5A):30S-34S. PubMed ID: 1746594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innovative use of porcine factor VIII:C for immune tolerance induction.
    Hay CR
    Am J Med; 1991 Nov; 91(5A):27S-29S. PubMed ID: 1746593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.